Organization (Academic)
UNIVERSITY OF TASMANIA
ClinicalTrials.gov lists UNIVERSITY OF TASMANIA as lead sponsor of 13 trials, counting the companies grouped under it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. Companies grouped under this one are not included. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 1 registered with a 2026 start date. The dashed outline is the pace from the 1 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 1.4 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers UNIVERSITY OF TASMANIA and 1 company grouped under it: 13 lead-sponsored trials (4 its own, 9 in the grouped companies) and 3 legal-entity registrations (2 its own, 1 in the grouped companies).
Companies grouped under this page (1)
| Company | Lead trials | Legal entities |
|---|---|---|
| Menzies Institute for Medical Research | 9 | 1 |
Disease areas (35)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Premature Birth | 3 |
| Alzheimer Disease | 2 |
| Dementia | 2 |
| Bone Diseases, Metabolic | 1 |
| Bronchopulmonary Dysplasia | 1 |
Showing 5 of 35 disease areas.
Trials by start year as sponsor or collaborator (10)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2024 | 2 |
| 2023 | 1 |
| 2022 | 2 |
| 2021 | 1 |
| 2019 | 3 |
| 2013 | 1 |
| 2006 | 1 |
| 1999 | 1 |
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Journals published in (47)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Archives of disease in childhood. Fetal and neonatal edition | 9 |
| Arthritis care & research | 2 |
| BMC musculoskeletal disorders | 2 |
| BMC neurology | 2 |
| BMC public health | 2 |
Showing 5 of 47 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 16 | 4 | 2025-11-04 |
Organization relationships (28)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| The University of Sydney | Co sponsors trial with | 2 |
| Lung Foundation Australia | Co sponsors trial with | 1 |
| University of Leeds | Co sponsors trial with | 1 |
| Cancer Care Ontario | Co sponsors trial with | 1 |
| Health New Zealand | Co sponsors trial with | 1 |
Showing 5 of 28 relationships.
Latest dated events (41)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-10 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-05-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-04-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-11-04 | Patent granted | Granted US patents (PatentsView / USPTO) |
| 2025-11-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 41 events.
Biomarker capability evidence (6)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| SERPINF2 | Trial collaborator | Named in trial inclusion criteria |
| AIM2 | Trial sponsor | Mentioned in trial text |
| AURKB | Trial sponsor | Mentioned in trial text |
| CRYBG1 | Trial sponsor | Mentioned in trial text |
| SERPINF2 | Trial collaborator | Mentioned in trial text |
Showing 5 of 6 evidence rows.
Biomarkers this organization publishes on (250)
Shown in this order: most publications first.
Showing 5 of 250 biomarkers.
Not on this page
Checked, with nothing recorded for this organization: related companies not grouped here, active development programs, approved assets, sponsor delivery record, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.